Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bonnie W. Ramsey, MD
Children's Hospital and Regional Medical Center, Seattle, Washington, USA
Principal InvestigatorKOL profile → - Stuart Elborn, MD
Respiratory Medicine Group, Queen's University of Belfast, Belfast, Northern Ireland, UK
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
65 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Children'S Hospital Westmead
Westmead, New South Wales, Australia
- the Prince Charles Hospital
Chermside, Queensland, Australia
- Royal Children'S Hospital Brisbane
Herston, Queensland, Australia
- Mater Adult Hospital
South Brisbane, Queensland, Australia
- Royal Children'S Hospital Melbourne
Parkville, Victoria, Australia
- Lung Institute of Western Australia
Nedlands, Western Australia, Australia
- Princess Margaret Hospital for Children
Subiaco, Western Australia, Australia
- Queen Elizabeth Ii Health Sciences Centre
Halifax, Nova Scotia, Canada
- Cf Center, Hospital for Sick Children
Toronto, Ontario, Canada
- St. Michael'S Hospital
Toronto, Ontario, Canada
- Montreal Children'S Hospital - Muhc
Montreal, Quebec, Canada
- Fn Motol
Prague, Czechia
- Hopital Cochin
Paris, France
- Hopital Necker
Paris, France
- Centre de Perharidy
Roscoff, France
- Kinder- Und Jugendklinik Universitätsklinikum Erlangen
Erlangen, Germany
- Mukoviszidose-Zentrum Am Klinikum Der Friedrich-Schiller-Universität Jena, Klinik Für Kinder- Und Jugendmedizin
Jena, Germany
- Klinikum Der Lmu München, Dr. Von Haunersches Kinderspital (cha)
Munich, Germany
- Universitäts-Kinderklinik Würzburg
Würzburg, Germany
- Cork University Hospital
Cork, Ireland
- Beaumont Hospital
Dublin, Ireland
- Our Lady'S Children'S Hospital
Dublin, Ireland
- St. Vincent'S University Hospital
Dublin, Ireland
- the National Children'S Hospital
Dublin, Ireland
- Belfast City Hospital
Belfast, Northern Ireland, United Kingdom
- Imperial College London
London, United Kingdom
- University of Alabama
Birmingham, Alabama, United States
- Kaiser Permanente Medical Care Program
Oakland, California, United States
- Cystic Fibrosis Research Office, Stanford University
Palo Alto, California, United States
- Rady Children'S Hospital
San Diego, California, United States
- National Jewish Medical and Research Center
Denver, Colorado, United States
- Emory Cystic Fibrosis Center
Atlanta, Georgia, United States
- St. Luke'S Cf Clinic
Boise, Idaho, United States
- Children'S Memorial Hospital
Chicago, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Iowa
Iowa City, Iowa, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Children'S Hospital Boston
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2009
- Primary completion
- 31 Jul 2010
- Completion
- 30 Nov 2012
- Last update posted
- 18 Jan 2013
- Registered enrollment
- 167
- Registry id
- NCT00909532
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.